Amgen Slashes Price on Cholesterol Drug Repatha — Now Selling Direct to Consumers

Amgen Slashes Price on Cholesterol Drug Repatha — Now Selling Direct to Consumers

THOUSAND OAKS, CALIFORNIA (VINnews)-Drug giant Amgen announced Monday it will start selling its cholesterol medication Repatha directly to U.S. consumers at a steeply discounted cash price — a move that comes amid growing political pressure to bring down drug costs. The company launched a new website, AmgenNow, where eligible Americans can buy Repatha for $239 […]

Amgen Latest Drugmaker to Respond to Trump’s Call to Reduce US Prices

Amgen announced that it will offer discounted, direct-to-consumer sales of Repatha, an injectable drug used to treat high cholesterol, through a new consumer portal. In an Oct. 6 statement, the company said the move was “in support of the Trump Administration’s efforts to lower drug prices for Americans.” The Thousand Oaks, California-based company joins Pfizer, which announced on Sept. 30 that Medicaid programs will have access to “most favored…

Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms

Today, Amgen announced the launch of AmgenNow, a direct-to-patient program offering evolocumab (Repatha) at nearly 60% below the current US list price.

Falls as It Cuts 60% Off Cholesterol Drug Price, Heeding Trump’s Clamor

Top American pharmaceutical firm Amgen (AMGN) on Monday unwrapped AmgenNow, its new direct-to-consumer platform. It kicked off the launch with a 60% discount on its popular cholesterol-reducing injection, Repatha. However, investors appear unimpressed with the move, with AMGN stock trending lower…